Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
neutralizing activity
Description:
The capacity of an antibody, antivenom, or other biological agent to inhibit the activity of a target molecule or pathogen.
Related topics:
Monoclonal and Polyclonal Antibodies Research (12%),
SARS-CoV-2 and COVID-19 Research (10%),
Venomous Animal Envenomation and Studies (8%)
OpenAlex ID:
keywords/neutralizing-activity
Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family
2005
·
Masahiko Mihara
, Keiko Kasutani
, et al.
·
International Immunopharmacology
·
363
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
2015
·
VRC 602 Study Team
, J E Ledgerwood
, et al.
·
Clinical & Experimental Immunology
·
268
The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins
2012
·
Shweta Tripathi
, Tesfaldet Tecle
, et al.
·
Journal of General Virology
·
228
Neutralizing antibodies for the prevention and treatment of COVID-19
2021
·
Lanying Du
, Yang Yang
, et al.
·
Cellular and Molecular Immunology
·
139
PDF
Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family
2002
·
Kemin Tan
, Bruce D. Zelus
, et al.
·
The EMBO Journal
·
129
PDF
Development of broad‐spectrum human monoclonal antibodies for rabies post‐exposure prophylaxis
2016
·
Paola De Benedictis
, Andrea Minola
, et al.
·
EMBO Molecular Medicine
·
118
PDF
Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1
2021
·
Ge Yang
, Ziyue Li
, et al.
·
Signal Transduction and Targeted Therapy
·
110
PDF
Age- and Sex-Associated Differences in the Glycopatterns of Human Salivary Glycoproteins and Their Roles against Influenza A Virus
2013
·
Yannan Qin
, Yaogang Zhong
, et al.
·
Journal of Proteome Research
·
97
Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses
2015
·
Shweta Tripathi
, Guangshun Wang
, et al.
·
PLoS ONE
·
94
PDF
Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
2020
·
Daniel Poston
, Yiska Weisblum
, et al.
·
Clinical Infectious Diseases
·
84
PDF
IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody
2019
·
Shinji Saito
, Kaori Sano
, et al.
·
PLoS Pathogens
·
83
PDF
Standardization of assays for testing the neutralizing ability of antivenoms
1990
·
JoséMaría Gutiérrez
, Gustavo Rojas
, et al.
·
Toxicon
·
83
Retained antigen-binding activity of Fab alpha fragments of human monoclonal immunoglobulin A1 (IgA1) cleaved by IgA1 protease
1986
·
B Mansa
, M Kilian
·
Infection and Immunity
·
82
Analysis of the Interaction between the HIV-Inactivating Protein Cyanovirin-N and Soluble Forms of the Envelope Glycoproteins gp120 and gp41
2000
·
Barry R. O’Keefe
, Shilpa R. Shenoy
, et al.
·
Molecular Pharmacology
·
79
Characterization of Molecular Features, Antigen-Binding, and in Vitro Properties of IgG and IgM Variants of 4E10, an Anti-HIV Type 1 Neutralizing Monoclonal Antibody
2004
·
Renate Kunert
, Susanne Wolbank
, et al.
·
AIDS Research and Human Retroviruses
·
78
Natural antibodies to IFN-gamma in man and their increase during viral infection.
1990
·
A Caruso
, C Bonfanti
, et al.
·
The Journal of Immunology
·
75
In Vitro and in Vivo Neutralizing Activity of Human Colostrum and Milk Against Purified Toxins A and B of Clostridium difficile
1984
·
K. Kim
, L. K. Pickering
, et al.
·
The Journal of Infectious Diseases
·
68
Differential Profiles and Inhibitory Effect on Rotavirus Vaccines of Nonantibody Components in Breast Milk From Mothers in Developing and Developed Countries
2013
·
Sung-Sil Moon
, Jacqueline E. Tate
, et al.
·
The Pediatric Infectious Disease Journal
·
65
Difference between follistatin isoforms in the inhibition of activin signalling:
2000
·
Osamu Hashimoto
, Nana Kawasaki
, et al.
·
Cellular Signalling
·
63
Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells
2017
·
Yehuda Z. Cohen
, Julio C. C. Lorenzi
, et al.
·
Journal of Virology
·
55
PDF
Characterization of gp120 and Its Single-Chain Derivatives, gp120-CD4D12and gp120-M9: Implications for Targeting the CD4iEpitope in Human Immunodeficiency Virus Vaccine Design
2005
·
Raghavan Varadarajan
, Deepak Sharma
, et al.
·
Journal of Virology
·
55
Betaglycan has Two Independent Domains Required for High Affinity TGF-β Binding: Proteolytic Cleavage Separates the Domains and Inactivates the Neutralizing Activity of the Soluble Receptor
2009
·
Valentín Mendoza
, M. Magdalena Vilchis-Landeros
, et al.
·
Biochemistry
·
53
A lipid inhibitor of dengue virus in human colostrum and milk; with a note on the absence of anti-dengue secretory antibody
1975
·
W. A. Falkler
, A. R. Diwan
, et al.
·
Archives of Virology
·
52
Role of membrane phospholipids and glycolipids in the Vero cell surface receptor for rubella virus
1990
·
P. Mastromarino
, L. Cio�
, et al.
·
Medical Microbiology and Immunology
·
49
Monoclonal Antibodies That Bind to Common Epitopes on the Dengue Virus Type 2 Nonstructural-1 and Envelope Glycoproteins Display Weak Neutralizing Activity and Differentiated Responses to Virulent Strains: Implications for Pathogenesis and Vaccines
2007
·
Andrew K. I. Falconar
·
Clinical and Vaccine Immunology
·
48
Show more works
View as search
Works count:
249
Citation count:
3,958
Year
Topic
Type